ABOUT TFS HEALTHSCIENCE
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 40 countries, TFS and its strategic partners provide tailored strategic resourcing solutions and clinical development services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.
FEATURED ARTICLES
-
![GettyImages-1407359737-dna-strand-gene-therapy]( "Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations")
This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.
-
![GettyImages-1001338254 DCT]( "Top Technologies Transforming Decentralized Clinical Trials")
In today’s clinical development environment, DCT technologies are not optional innovations; they are essential drivers of more resilient, efficient, and patient-focused trials.
-
![GettyImages-1288871608-doctors-tablet-sofware-office-setting]( "Data-Driven Decision-Making In Clinical Trials")
By leveraging real-time data and predictive tools, sponsors and CROs can address the increasing complexity of trials, accelerate therapeutic development, and proactively manage risks.
-
![GettyImages-107698014_DMD wheelchair]( "Huntington's Disease Clinical Trials: Innovation, Challenges, And The Road Ahead")
The Huntington’s disease (HD) landscape is undergoing rapid transformation driven by breakthroughs in gene-targeted therapies, small-molecule modulators, regenerative medicine, and digital innovation.
-
![AI technology-GettyImages-2196492370]( "Leveraging AI To Transform Neurodegenerative Drug Development")
Explore how AI is redefining the development pipeline for neurodegenerative diseases (NDDs), offering a path forward in the quest for effective, disease-modifying treatments.
-
![Business Partners Negotiating Deal-GettyImages-1424912318]( "How Strategic Resourcing Accelerates Biotech's Path From Preclinical To FIH")
Explore how strategic resourcing, particularly through FSP models, empowers biotech sponsors to overcome common hurdles transitioning when from preclinical research to first-in-human (FIH) trials.
-
![GettyImages-1987430372-business-consulting-office-table-graphs-tablet]( "Innovative FSP Solutions For Biopharma Growth And Transition")
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Harnessing RWE For Effective External Control Arms In Clinical Trials")
Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.
-
![GettyImages-1332585814 oncology patient nurse]( "What To Look For In An Oncology CRO")
Learn seven of the critical factors for choosing an oncology-focused CRO that enable sponsors to identify partners aligning with their clinical research objectives.
-
![AI artificial intelligence-GettyImages-1249307327]( "Advancing Neuroscience Research With Data-Driven Innovations And AI")
Learn how to employ data-driven insights, artificial intelligence, and decentralized clinical trials to accelerate drug development and address the intricate challenges of neuroscience research.
-
![iStock-1152216276-skin-dermatology]( "Dermatology Drug Development: Key Takeaways From AAD 2025")
The 2025 American Academy of Dermatology (AAD) Annual Meeting underscored pivotal advancements in dermatology drug development, highlighting the essential role of innovative dermatology CROs.
-
![Cancer Immunotherapy research concept 450x300]( "Navigating The Evolving Landscape Of Immunotherapy in Oncology")
Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.
-
![GettyImages-663578188-Nucleic-acid-double-helix]( "Pioneering Gene Therapy In Rare Diseases")
Overcoming barriers to gene therapy development requires continued innovation in manufacturing processes, harmonized regulatory approaches, and outcome-based pricing models.
-
![Health in europe-GettyImages-1220562866]( "Evolution Of Clinical Trials In Europe")
The CTR and CTIS represent a paradigm shift in European clinical research, fostering a more efficient and transparent trial environment.
-
![GettyImages-547131922 research, regulatory, lab]( "The Future Of Good Clinical Practice: The ICH E6(R3) Update")
The release of the ICH E6(R3) Good Clinical Practice guideline in January 2025 marks a shift in clinical research, with significant implications for CROs, trial design, and quality management.
-
![GettyImages-2190227480-laboratory-scientists-computer-equipment-research]( "The Power Of Immunotherapy And Precision Medicine In Cancer Research")
Learn about the key criteria that sponsors should evaluate when selecting a partner for your IO trials to help them improve efficiency, and accelerate the development of life-saving cancer treatments.
-
![GettyImages-1651634560-telemedicine-cream-skin-dermatology]( "The Role Of Technology In Transforming Dermatology Clinical Trials")
AI and data-driven innovations are transforming dermatology clinical trials by enhancing efficiency, data accuracy, and patient access.
-
![GettyImages-1152606724 patient centricity]( "Epidermolysis Bullosa: Future Perspectives In Drug Development")
Recent breakthroughs are signaling a promising shift in the landscape of Epidermolysis bullosa (EB) care from focusing on pain management to a growing commitment to curative strategies.
-
![GettyImages-1480892977-doctor-gene-dna-brain-lungs-heart]( "Gene Therapy In Neurology: The Case For Optimism")
Advancements in genetic therapy are revolutionizing the treatment of neurological diseases, with promising results from preclinical studies leading to clinical trials focused on safety and efficacy.
-
![GettyImages-1204781345 doctor tablet meeting]( "Maximizing Efficiency: A Comprehensive Guide To Study Coordination Services")
Explore the critical role of study coordinators, emphasizing their expertise, strategic contributions, and the value they add to clinical research.
CONTACT INFORMATION
TFS HealthScience
2530 Meridian Parkway Suite 300
Durham, NC 27713
UNITED STATES
Phone: +46 (0)46 280 18 00
Contact: info@tfscro.com
FEATURED PRODUCTS
TFS HEALTHSCIENCE CASE STUDIES
-
![eye drops-GettyImages-1406386094]( "Rapid Results In A High-Stakes Dry Eye Disease Trial")
This time-sensitive Phase 3 trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.
-
![GettyImages-820772090 eyes]( "Global Start-Up For Multinational Geographic Atrophy Trial")
This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.
-
![GettyImages-1441381006 budget talks]( "Precision Project Management In Action")
Discover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).
-
![GettyImages-1169621483-injection-arm-line-trial]( "Driving Early-Phase Success In Advanced Solid Tumors Study")
A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.
-
![GettyImages-2036497698 clinical lab]( "Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies")
To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.
-
![Nurse and oncology patients-GettyImages-1480325057]( "Streamlining Phase I/II Oncology Trials: A Global CRO Partnership")
Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.
-
![GettyImages-1200984194 elderly mobility]( "Tailored Solutions For A Global Phase III Neovascular AMD Study")
How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
-
![GettyImages-1400967286 regulations computer]( "Optimizing Early-Stage Oncology")
A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.
-
![GettyImages-693602906-trial site selection]( "Addressing Site Selection Challenges In DMD Gene Therapy Studies")
Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.
